Established in 1984, this manufacturer is a certified CTD dossier owner and manufacturer, offering over 150 pharmaceutical products across local and international markets. As a GMP manufacturer, it operates an ISO 9001:2015 certified facility in Dhaka, Bangladesh, with ideal machinery and skilled professionals. With a workforce of approximately 500, this CTD dossier owner and manufacturer ensures consistent quality through GMP-compliant production lines, reinforcing its global reach as a GMP manufacturer and CTD dossier owner and manufacturer.

This CTD dossier owner and manufacturer specializes in the manufacturing, import, and export of a diverse range of healthcare products. Their portfolio includes over 300 registered pharmaceutical products spanning various therapeutic areas, primarily delivered through tablets, capsules, dry suspensions, injectables, and sachets. The company operates a state-of-the-art manufacturing facility equipped with modern technology to ensure high-quality production according to international standards. They are committed to research and development, aiming to provide innovative healthcare solutions globally. Their focus extends beyond manufacturing, encompassing market research and the promotion of pharmaceutical products across regions like the EU and North America.

This CTD dossier owner and manufacturer is a prominent player in the pharmaceutical industry, specializing in both human and animal health products. Their diverse portfolio includes branded generics, biologics, injectables, personal hygiene items, and consumer products. They boast a state-of-the-art GMP-compliant facility and have established subsidiaries to focus on specific areas like carbapenem injectables and consumer goods. The company is recognized for its commitment to quality, evidenced by certifications such as ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. They have a strong presence in regions like the EU, North America, Asia, and the Middle East. Key therapeutic areas include infectious diseases and mental health, with principal dosage forms encompassing oral solutions, tablets, injectables, and topical creams. The company actively invests in research and development to bring innovative products to market.